The repertoire of serous ovarian cancer non-genetic heterogeneity revealed by single-cell sequencing of normal fallopian tube epithelial cells

The repertoire of serous ovarian cancer non-genetic heterogeneity revealed by single-cell sequencing of normal fallopian tube epithelial cells

The inter-differentiation between cell states promotes cancer cell survival under stress and fosters non-genetic heterogeneity (NGH). NGH is, therefore, a surrogate of tumor resilience but its quantification is confounded by genetic heterogeneity. Here we show that NGH in serous ovarian cancer (SOC)...

Full description

Bibliographic Details
Main Authors:	Hu, Z, Artibani, M, Alsaadi, A, Wietek, N, Morotti, M, Shi, T, Zhong, Z, Santana Gonzalez, L, El-Sahhar, S, KaramiNejadRanjbar, M, Mallett, G, Feng, Y, Masuda, K, Zheng, Y, Chong, K, Damato, S, Dhar, S, Campo, L, Campanile, R, Soleymani majd, H, Rai, V, Maldonado-Perez, D, Jones, S, Cerundolo, V, Sauka-Spengler, T, Yau, C, Ahmed, AA
Format:	Journal article
Language:	English
Published:	Cell Press 2020

Similar Items

Single-cell transcriptomics identifies a WNT7A-FZD5 signaling axis that maintains fallopian tube stem cells in patient-derived organoids
by: Alsaadi, A, et al.
Published: (2023)

A highly accurate platform for clone-specific mutation discovery enables the study of active mutational processes
by: KaramiNejadRanjbar, M, et al.
Published: (2020)

An evolving story of the metastatic voyage of ovarian cancer cells: Cellular and molecular orchestration of the adipose-rich metastatic microenvironment
by: Motohara, T, et al.
Published: (2018)

Mechanistic drivers of Müllerian duct development and differentiation into the oviduct
by: Santana Gonzalez, L, et al.
Published: (2021)

Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor initiating cells
by: Artibani, M, et al.
Published: (2021)

Mechanistic Drivers of Müllerian Duct Development and Differentiation Into the Oviduct
by: Laura Santana Gonzalez, et al.
Published: (2021-03-01)

Single-cell transcriptomics identifies a WNT7A-FZD5 signaling axis that maintains fallopian tube stem cells in patient-derived organoids
by: Abdulkhaliq Alsaadi, et al.
Published: (2023-11-01)

The somatic mutational landscape of the normal fallopian tube epithelium
by: Wietek, N
Published: (2021)

Bilateral Primary Papillary Serous Carcinoma of the Fallopian Tube
by: H.K. Manjunatha, et al.
Published: (2017-05-01)

Serous Adenocarcinoma of Fallopian Tubes: Histological and Immunohistochemical Aspects
by: Natalia Hyriavenko, et al.
Published: (2019-07-01)

A highly accurate platform for clone-specific mutation discovery enables the study of active mutational processes
by: Eli M Carrami, et al.
Published: (2020-04-01)

Fallopian tube origin of supposed ovarian high-grade serous carcinomas
by: Patricia Martini Diniz, et al.
Published: (2011-01-01)

Occult serous carcinoma of fallopian tube presenting as supraclavicular lymphadenopathy
by: Meryem Kurek Eken, et al.
Published: (2016-06-01)

High grade serous ovarian carcinomas originate in the fallopian tube
by: S. Intidhar Labidi-Galy, et al.
Published: (2017-10-01)

Comparison of early-stage primary serous fallopian tube carcinomas and equivalent stage serous epithelial ovarian carcinomas
by: Huann-Cheng Horng, et al.
Published: (2014-12-01)

Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies
by: Hellner, K, et al.
Published: (2016)

Primary High Grade Serous Carcinoma of the Fallopian Tube: A Case Report
by: Ramesh Dhakhwa, et al.
Published: (2020-11-01)

Neuroendocrine Tumor of the Fallopian Tube and Serous Adenocarcinoma of the Ovary: Multicentric Primary Tumors
by: Nataliia HYRIAVENKO, et al.
Published: (2023-05-01)

Serous borderline tumor of the fallopian tube presented as hematosalpinx: a case report
by: Smiljan-Severinski Neda, et al.
Published: (2005-10-01)

Fallopian tube secreted protein affects ovarian metabolites in high grade serous ovarian cancer
by: Tova M. Bergsten, et al.
Published: (2022-11-01)

Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cells
by: Mara Artibani, et al.
Published: (2021-06-01)

Magnetic resonance imaging in diagnosis of serous adenocarcinoma of fallopian tubes: a case report
by: Oleg I. Mynko, et al.
Published: (2024-11-01)

Solitary CNS Metastasis on Initial Presentation of High Grade Serous Carcinoma of the Fallopian Tube
by: Felicity Harl, et al.
Published: (2018-01-01)

Bilateral primary papillary serous carcinoma of the fallopian tube – A rare case scenario
by: Satish Arakeri
Published: (2023-01-01)

Identification of fallopian tube stem cells using patient-derived organoids
by: Alsaadi, A
Published: (2021)

Focal Serous Tubal Intra-Epithelial Carcinoma Lesions Are Associated With Global Changes in the Fallopian Tube Epithelia and Stroma
by: Jingni Wu, et al.
Published: (2022-03-01)

BRCA-2 (+) high-grade serous fallopian tube cancer diagnosed as an isolated breast mass by mammography
by: Janelle N. Sobecki, et al.
Published: (2021-02-01)

Secretory cell outgrowths, p53 signatures, and serous tubal intraepithelial carcinoma in the fallopian tubes of patients with sporadic pelvic serous carcinoma
by: Neha Mittal, et al.
Published: (2016-01-01)

Bilateral primary fallopian tube papillary serous carcinoma in postmenopausal woman: Report of two cases
by: Dipanwita Nag, et al.
Published: (2016-01-01)

Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube
by: Junzheng Yang, et al.
Published: (2017-06-01)

A mini-review regarding the carcinogenesis and morphology of serous tumors of the ovary, fallopian tube and peritoneum
by: Tiberiu-Augustin Georgescu, et al.
Published: (2021-04-01)

Proteomic Analysis of Pre-Invasive Serous Lesions of the Endometrium and Fallopian Tube Reveals Their Metastatic Potential
by: Mitchell Acland, et al.
Published: (2020-12-01)

Premalignant SOX2 overexpression in the fallopian tubes of ovarian cancer patients: Discovery and validation studies
by: Karin Hellner, et al.
Published: (2016-08-01)

Fallopian tube single cell analysis reveals myeloid cell alterations in high-grade serous ovarian cancer
by: Joshua Brand, et al.
Published: (2024-03-01)

Serous carcinoma of a prolapsed fallopian tube: A rare cause of a vaginal apex mass
by: Tyler J. Woodard, et al.
Published: (2020-08-01)

Can morphometric analysis of the fallopian tube fimbria predict the presence of uterine papillary serous carcinoma (UPSC)?
by: Amnon Amit, et al.
Published: (2019-01-01)

Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma
by: Shuang Zhang, et al.
Published: (2019-11-01)

Chlamydia trachomatis infection in primary fallopian tube and high-grade serous ovarian cancers: a pilot study
by: Laban M, et al.
Published: (2019-03-01)

Cardiophrenic lymph node metastasis as the sole presentation of high grade serous ovarian carcinoma
by: Thomas Julius Henning, et al.
Published: (2024-09-01)

Assessing the impact of deep‐learning assistance on the histopathological diagnosis of serous tubal intraepithelial carcinoma (STIC) in fallopian tubes
by: Joep MA Bogaerts, et al.
Published: (2024-11-01)